Staph was President and Chief Operating Officer at Clinton Health Access Initiative, and Advisory Board Member at Leapfrog Investments. Staph Leavenworth joined LimmaTech Biologics in 2024.
Staph Leavenworth is currently
Create your alert
to follow the career of Staph Leavenworth.
Do you need to know more about Staph Leavenworth? More results.
Report an error
Update the org chart details of Staph Leavenworth.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.